Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:26:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed information about a clinical trial for thymic carcinoma and the addition of new identifiers and collaborators, indicating a shift in focus or a revision of the trial's details.
    Difference
    52%
    Check dated 2025-04-16T20:53:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added, indicating a potential change in content or features effective from March 6, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T16:08:18.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 6, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-02T00:34:33.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing several past dates and adding new ones for 2025, indicating a shift in the timeline of events or updates.
    Difference
    0.9%
    Check dated 2025-03-11T09:00:04.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-24T23:17:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.